NorthWest Biotherapeutics Inc (NWBO)

[Lykiri]

Thanks!

Pietro Ivo D'Urso MD FRCS@pidurso
#BNOS2022 if anyone can, Ash…Kan! Fantastic presentation of Prof Ashkan: exciting results from the Phase 3 trial of #DCVax-L in Glioblastoma
@BNOSofficial@KingsNeuro

#BNOS2022 if anyone can, Ash…Kan! Fantastic presentation of Prof Ashkan: exciting results from the Phase 3 trial of #DCVax-L in Glioblastoma @BNOSofficial @KingsNeuro pic.twitter.com/xDpZBYnZa1

— Pietro Ivo D'Urso MD FRCS (@pidurso) June 23, 2022

Sally Price@saspist
Prof Ashkan @KingsNeuro presenting promising results for DCVax for GBM with 2.8mo OS improvement, marked change in long term survival. Also slide showing predictors for good outocome. #bnos2022

Prof Ashkan @KingsNeuro presenting promising results for DCVax for GBM with 2.8mo OS improvement, marked change in long term survival. Also slide showing predictors for good outocome. #bnos2022 pic.twitter.com/RPrO2sUV06

— Sally Price (@saspist) June 23, 2022

Benjamin Sanderson@Benji_Sanderson

RECURRENT GBM!! #DCVax #BNOS2022
@BNOSofficial@NorthwestBio

https://mobile.twitter.com/Benji_Sanderson/status/1539906381070876672/photo/1

Benjamin Sanderson@Benji_Sanderson
DCVax in GBM. An extremely exciting novel area with VERY encouraging results.
@NorthwestBio #BNOS2022 @BNOSofficial@

https://mobile.twitter.com/Benji_Sanderson/status/1539902600996421632

Benjamin Sanderson@Benji_Sanderson
Oooooo, hello you. #BNOS2022 @NorthwestBio #braintumournorthwest

Oooooo, hello you. #BNOS2022 @NorthwestBio #braintumournorthwest pic.twitter.com/Hl1alIE0gl

— Benjamin Sanderson (@Benji_Sanderson) June 23, 2022

Benjamin Sanderson@Benji_Sanderson
Even a benefit in patients with significant residuum! #BNOS2022

https://mobile.twitter.com/Benji_Sanderson/status/1539906370467729408

Benjamin Sanderson@Benji_Sanderson
External controls to circumvent this problem. Elegant but I fear this will cast significant doubt and shadow over what may be a truly fantastic development in treatment of GBM. Feelings reminiscent of EF-14 trial. #BNOS2022@BNOSofficial

External controls to circumvent this problem. Elegant but I fear this will cast significant doubt and shadow over what may be a truly fantastic development in treatment of GBM. Feelings reminiscent of EF-14 trial. #BNOS2022 @BNOSofficial pic.twitter.com/KCHsUbA1zA

— Benjamin Sanderson (@Benji_Sanderson) June 23, 2022

HCEngagement@EngagementHc
#BNOS2022 Listening to The Prof talking about Autlogous Tumour Lysate-Loaded Dendritic Cell Vaccination for Glioblastoma trial data
@KingsNeuroLab@KingsNeuro@BrainTumourOrg

https://pic.twitter.com/1NOSwKGH3K

#BNOS2022 Listening to The Prof talking about Autlogous Tumour Lysate-Loaded Dendritic Cell Vaccination for Glioblastoma trial data @KingsNeuroLab @KingsNeuro @BrainTumourOrg https://t.co/1NOSwKGH3K pic.twitter.com/Y1cSbeuD3i

— HCEngagement (@EngagementHc) June 23, 2022

Shaveta Mehta@shaveta_mehta
Prof Ashkan sharing the results of Phase 3 trial of DCVax in GBM #BNOS2022 @BNOSofficial

Prof Ashkan sharing the results of Phase 3 trial of DCVax in GBM #BNOS2022 @BNOSofficial pic.twitter.com/iyEh5aL12R

— Shaveta Mehta (@shaveta_mehta) June 23, 2022